TY  - JOUR
T1  - An Overview on Thalassemia Diagnosis and Management Approach, Literature Review
A1  - Tahani Mohammed Manea
A1  - Faris Suhail Abdalhameed Khan
A1  - Renad Mohammed Alsharyufi
A1  - Kholoud Mohammed Alghamdi
A1  - Manal Khalaf Alzahrani
A1  - Fawaz Mohammed Alzubaidi
A1  - Ali Abdulaziz Alghanmi
A1  - Turki Abdullah Almahdawi
A1  - Turki Mohammed Alhasani
A1  - Nermeen Nasser Alrajhi
JF  - International Journal of Pharmaceutical Research and Allied Sciences
JO  - Int J Pharm Res Allied Sci
SN  - 2277-3657
Y1  - 2021
VL  - 10
IS  - 2
DO  - 10.51847/JOXooiGiVQ
SP  - 103
EP  - 107
N2  - Thalassemia syndromes are the most common inherited monogenic diseases that kill and affect millions of people worldwide. As Thalassemic diseases became a healthcare system burden for many countries around the world Thalassemia management emerges as a lifetime treatment program that should regularly be monitored with preferable choice for management. In this review we aim to collect and summarize recent articles, studies, and clinical trials in diagnosing and managing thalassemia, and provide a summarized, yet comperhansive study. PubMed database was used for this review and data was collected from relevant journal articles, randomized controlled trials, and observational studies containing the term used in the mesh “Thalassemia” “Management” “Diagnosis” “Laboratory” “Treatment” within the title or abstract. The major pathophysiological change that occurs in thalassemia is the imbalance of the globin chain production. Thalassemia management emerges as a lifetime treatment program that includes intensive medical and surgical care with ongoing monthly clinical visits. 
UR  - https://ijpras.com/article/an-overview-on-thalassemia-diagnosis-and-management-approach-literature-review-321yn592txhv44j
ER  -